Chapter 185 Siemens’ countermeasures!
Rongcheng Third People's Hospital, Dean's Office.
Dean Zhou’s full name is Zhou Yongren. As early as when Tsingshan Pharmaceutical first developed “ITG human myelopoietin”, Dean Zhou established a good personal relationship with Zhang Yang and reached an agreement with Tsingshan Pharmaceutical. strategic partners.
In recent years, Qingshan Pharmaceutical has not lived up to expectations, with its products such as "ITG human myelopoietin", "Ikefenprovir", "hepatocyte activator", and "renal dialysis needle". Innovative drugs are placed in the Third People's Hospital for exclusive clinical trials, which also brings countless patients to the Third People's Hospital for treatment.
The medical resources of key departments such as the Department of Hematology, the Department of Hepatology, and the Department of Nephrology have significantly improved, and the department rankings have also improved significantly!
You must know that the annual ranking of each major department determines the hospital's annual comprehensive score, and the comprehensive score is largely an assessment of the dean and reflects to a large extent how well the hospital dean is doing.
Looking at the comprehensive score he estimated and calculated in front of him, Dean Zhou frowned worriedly.
There will be a new personnel adjustment in less than half a year. Of course he does not want to continue to stay in the position of dean. Of course he wants to go further.
According to the original plan, or goal, his next position was aimed at the deputy director of the Chengdu City Health Commission.
This is an important functional department that can coordinate and plan the medical policies, medical supervision and other work of the entire Chengdu city. It can be said that once you are transferred from the hospital to the deputy bureau, it will rise from the micro-management of the hospital to the entire regional medical management. Macro management.
It’s heart-warming to think about it.
But...
Although I have indeed achieved very good results with the help of Qingshan Pharmaceutical in recent years, the hospital's overall profitability, medical resources, and highly educated doctors have also They have all made tremendous improvements,
but he also knows that the other dean who competes with him for the deputy bureau has also done a good job in these years!
It would be a lie to say you are not worried.
"It would be great if we could build another star department in the next half year and break into the top 50 in the country!"
"In this way, my position as deputy director will definitely be stable!"
Dean Zhou sighed inwardly and couldn't help but rub his temples.
It sounds simple to say, but currently the only one that can really achieve some results quickly is the "nano nodule developer" that Tsingshan Pharmaceutical is undergoing phase II clinical trials.
The problem is that the number of patients recruited in the second and third clinical phases is fixed. Although these patient data can improve some rankings, it is still very difficult to enter the top 50 departments in the country at once!
Moreover, the ranking of a department also depends on the average daily number of patient operations. Once the "nano nodule imaging agent" is fully launched, a large number of patients will inevitably be diverted. How can the department have a continuous flow of patients?
Hey, it would be great if I could have it all to myself for a month!
In one month, one CT can take pictures of 200 patients a day, or 6,000 in a month.
It won’t take more than a month, it will be almost stable after half a month!
How can you get half a month of exclusivity?
Dean Zhou shook his head. At this moment, the office door was suddenly pushed open, and Ouyang, the newly appointed director of thoracic surgery, walked in with a stack of information.
"Yuan Zhou, I have already sorted out the information you asked me to sort out. Please take a look at it."
Dean Zhou raised his head and glanced at the newly promoted Director Ouyang, with a frown on his face. Show some kindness.
I have to say here that Director Liu of the Thoracic Surgery Department of the Third People's Hospital had been fired by Director Zhou. Because he could judge Feng Gang's benign nodules as malignant, he suffered a knife attack in vain. Dean Zhou lost trust in him.
Just because Qingshan Pharmaceutical’s “Nano Nodule Developer” was in exclusive clinical trials at Sanren Medical, it attracted many young and powerful doctors to inquire, so they simply replaced it with the more capable Director Ouyang. .
"Thank you for your hard work."
Dean Zhou took over the data compiled by Director Ouyang and began to look through it. Director Ouyang on the side saw this and said:
"I compiled this 'nano junction' Section 1 and 2 of the clinical phase 1 and 2 clinical trials of all the surgical data in our hospital ”
“In us. There are a total of 263 surgeries performed in the department, of which 221 are minimally invasive surgeries, 31 are thoracotomy surgeries, and the remaining 11 are more difficult..."
"However, there are only more than 260 surgeries. For Taiwan surgery, it is estimated that it will be difficult for our department to improve its ranking significantly.”
Dean Zhou frowned, knowing the difficulty.
The most important scoring criteria in department rankings are "case data" and "scientific research capabilities."
It goes without saying about "scientific research capabilities". The Department of Thoracic Surgery at Sanren Medical Hospital has no scientific research capabilities at all, so the most important thing is case data and surgical data.
More than 260 surgeries are obviously not enough.
“Furthermore, Zhou Yuan, I just got some not-so-good news. It is said that Qingshan Pharmaceutical’s ‘nodule developer’ has very good clinical phase II data, and the State Administration of Supervision is considering significantly reducing its clinical use. The number of subjects in Phase III will speed up its marketing application.”
Reduce the number of clinical phase III subjects?
Dean Zhou frowned deeper.
According to the conventional clinical process for innovative drugs, the first clinical phase has the smallest number of people, the second phase has about a hundred people, and the third phase has as many as 500-1,000 people.
But "nodule developer" is not a traditional drug, it is just a fluorescent reagent, and can even be classified into the category of "medical consumables"!
With the accuracy rate of 100% in the second phase, it is in line with the regulations to reduce the number of people in the third phase.
But...
Dean Zhou was startled and then reacted.
The smaller number of clinical phase III subjects is of course a good thing for Qingshan Pharmaceutical, but it is not a good thing for myself and the Thoracic Surgery Department of Chengdu Third People’s Hospital!
Dean Zhou’s painful expression fell in the eyes of Director Ouyang. Of course, he knew to some extent that Dean Zhou was competing for deputy director, and he also knew that Dr. Zhou very much hoped to improve the ranking of thoracic surgery again. Mention it.
But,
The data of 260 surgeries in the first and second clinical phases is obviously not enough. If there are only 100 surgeries in the third clinical phase, it will definitely not be enough to improve the ranking.
Then there’s really nothing we can do.
Thinking of this, Director Ouyang couldn't help but sigh. After a moment, he suddenly thought of another thing!
"By the way, Zhou Yuan, there is one more thing I want to report to you."
"The CT machine manufacturer Elephant Medical that cooperates with Qingshan Pharmaceutical has been confirmed a few days ago.' The official price of a developing CT machine is 8 million yuan each, which is not too expensive. ”
"But I heard that their only requirement is that they will not ship and install it until Qingshan Pharmaceutical's 'nodule developer' is on the market."
"Huh?"
"Yes. Will it be shipped and installed after Qingshan Pharmaceutical’s ‘Nodule Developer’ is launched?”
Dean Zhou was still immersed in the pain of only 100 subjects in the third phase of the clinical trial and did not notice it. The words were strange.
But at this moment, the cell phone on the desk suddenly rang, it was Zhang Yang.
Before he could speak, Zhang Yang took the lead and said:
"Yuan Zhou, didn't you order a 'nodule imaging CT machine' from Elephant Medical before? When is it convenient for you, I'm here I'll arrange for someone to come to your door and install it."
Dean Zhou gradually came to his senses and remembered what Director Ouyang said just a second ago.
He was suddenly a little surprised and said in surprise:
"Zhang Yang, I just heard that your 'nodule imaging CT machine' has to wait for Qingshan Pharmaceutical's 'nodule developer' to be launched. It will be shipped and installed later.” “Why do you suddenly have to ship it to us?”
Zhang Yang laughed and explained:
"Zhou Yuan, your information is really well-informed."
"That's right, our 'nodule developer' will be here soon We are about to conduct phase 3 clinical trials. I estimate that 100 will be used in phase 3. It will take about a month for the test subjects to be completed, and it will be successfully launched in a month and a half at most."
"Just install it in advance. Once the 'developer' is put on the market, you will be the first. The time will be put to good use.”
Dean Zhou was stunned for a moment, then said:
"Then why didn't you ship the orders from other hospitals together?"
But as soon as the words came out of his mouth, he suddenly trembled, and everything came to him at once. Understood.
After a moment, a warm current suddenly surged through his heart, and his voice could not help but become low, surprised, and unbelievable:
"Zhang Yang, what you mean is that you asked Elephant Medical to only give Did we ship the goods in advance?”
"Are you deliberately leaving time for us? Let our Third People's Hospital monopolize the 'developer' for a period of time?"
Zhang Yang did not hide it and said with a smile:
"That's right. I asked them to wait for the 'developer' to be released before shipping it."
"This way. As a result, you will have about half a month to yourself! In this half month, only your Third People's Hospital can perform the 'pulmonary nodule scan'. I believe it will be very helpful to your patients, right?"
“Zhou Yuan, you can seize the opportunity!”
"Zhang Yang..."
After receiving the confirmation, Dean Zhou's heart was already surging.
He originally wanted to ask something like "Why are you so nice to me?", but all the words on his lips seemed to pale.
He and Zhang Yang have known each other since "ITG Human Myelopoietin", and Zhang Yang seems to have always been like this for so many years!
After being silent for dozens of seconds, he suddenly whispered:
"Thank you, thank you for your publicity!"
"Haha, Zhou Yuan is too polite. Please quickly arrange for someone to receive the CT machine. Our people have arrived, that's it, hang up first!"
Zhang Yang's call came and went quickly.
He had no time to sigh, and hurriedly ordered Director Ouyang to go to the CT room to receive Elephant Medical's "nodule imaging CT machine"
Director Ouyang left quickly, leaving only Zhou Zhou in the office The dean alone, his eyes fell on the phone number displayed on the screen of his mobile phone, and he couldn't help but let out the excitement in his heart.
"Zhang Yang...I remember your friendship!"
"You helped me get to the deputy bureau, and I will repay you a hundredfold when the time comes!"
Unknowingly, Zhou Yuan I made a promise in my heart.
……
The news that the Elephant Medical CT machine “will not be shipped until the ‘nodule contrast agent’ is on the market” quickly spread among the purchasing departments of major hospitals.
Although major hospitals feel a little strange, they can accept it.
As explained by Elephant Medical, the "nodule development function" of CT can only be officially used after the "nodule developer" is launched, and it will not be too late to install it by then.
Of course, not all hospitals expressed doubts.
After all, any manufacturer that produces medical devices is eager for customers to place orders quickly and deliver the equipment to the hospital. Only Elephant Medical is delaying delivery. Is this because it makes too much money? ?
However, although everyone has some complaints, because it far exceeds psychological expectations, only 8 million can buy a "nodule imaging CT machine", major hospitals, Xiehe, Huaxia, Ruijin , Modu Cancer Hospital, etc. all signed the purchase contract very readily.
A week later, Elephant Medical Headquarters in Shanghai.
Mao Zhiqiang couldn’t suppress the smile on his face when he saw the orders flying back like flakes!
In just one week, a total of 14 well-known domestic hospitals have signed purchase agreements with Elephant Medical, purchasing as many as 58 units!
You must know that each "nodule imaging CT machine" has a gross profit of 35%. Calculated, one machine can earn 2.8 million, and 58 machines are 160 million!
In the past, this was a profit of a year or even more than a year!
"It's great! It's so great. This thigh hug is really worth it!"
......
Mao Zhiqiang was delighted with the good start of Elephant Healthcare. On the other hand, Siemens headquarters also noticed the gains of Elephant Healthcare. A large number of hospital orders are growing rapidly!
The source of everything is the "nodule developer" from Qingshan Pharmaceutical!
Actually,
As early as after Zhang Yang withdrew his intention to cooperate with Siemens, Siemens headquarters noticed Qingshan Pharmaceutical's "nodule developer" that could change the CT machine market structure. Vice President Peter even flew to China for the first time to personally Talk and cooperate with Zhang Yang.
However,
by the time Vice President Peter discussed cooperation with Zhang Yang, Qingshan Pharmaceutical had already cooperated with Elephant Medical, so Zhang Yang directly refused.
When Vice President Peter expressed the hope that Elephant Medical would not monopolize the patent and was willing to cooperate and pay patent fees, Zhang Yang had already taken the lead to obtain 50% of the shares of Elephant Medical, and in the end he had no choice but to reject Siemens. request for cooperation.
Of course, anyone else would definitely be willing to cooperate with Siemens. After all, Siemens is completely different in size from Elephant Medical.
But Qingshan Pharmaceutical earns tens of billions of profits a year, and Zhang Yang really doesn't care much about Siemens' patent fees.
That’s it,
The cooperation between Siemens headquarters and Qingshan Pharmaceutical has ended before it even started.
Siemens headquarters in Germany.
In a spacious, bright and technological conference room, Peter, the vice president who had met Zhang Yang once before, sat on the left side of the conference table. Today he is the host of this meeting.
There were six other senior executives on both sides of him. Except for President Tobias, the rest were all vice presidents in charge of various businesses like him.
He glanced at President Tobias, saw him nodding, and then coughed lightly and said:
“Everyone is here, so let me talk about the latest news first. The situation! ”
“We all already know that Qingshan Pharmaceutical, a well-known pharmaceutical company in China, has developed a drug called ‘Nano Nodule’. developer's medicine, and reached a cooperation with one of our direct competitors in China, 'Elephant Medical'"
"A week ago, Elephant Medical officially started selling their nodule imaging CT. Machine', and immediately reached a large number of purchase contracts with major hospitals in China! ”
"According to the data we have obtained, their first batch of purchase orders is as high as nearly 60 units. This data has reached one-half of our annual sales in the Chinese market!"
"The most disappointing thing I am surprised that the price of their “development CT machine” is only 8 million!”
“I have seen the huge impact they have had on our product line!”
( End of chapter)